Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for BASFY and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for BASFY and 80,000+ other tickers.
See exactly how BASFY's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BASFY and 80,000+ other tickers.
BASF SE stands as a globally operating chemical enterprise, diversifying its extensive activities across six key segments. The Chemicals division primarily supplies foundational building blocks such as petrochemicals and intermediate products. The Materials segment is dedicated to developing and delivering sophisticated materials and their precursors, including specialized polymers like isocyanates and polyamides, as well as essential inorganic products and niche specialties for the plastics manufacturing industry. Industrial Solutions innovates and distributes a broad array of ingredients…
BASF launches GLYTHERMIN coolants to meet rising AI data center cooling needs, combining advanced corrosion protection with thermal management solutions.
BASF could make a higher offer for Evonik if there are talks with the specialty chemicals maker, sources close to BASF told Reuters on Friday.
BASFY expands Ultradur RC1 with up to 30% recycled PET, targeting high-performance automotive parts and customers' sustainability goals.
German chemicals maker Evonik has rejected a takeover offer of about €22.15 per share from larger peer BASF as too low, two people familiar with the matter told Reuters on Monday.
Evonik has rejected a €10.3 billion ($11.7 billion) takeover bid from BASF for being too low to warrant formal negotiations or to allow its competitor to carry out due diligence, the Financial Times reported on Monday.